Evgen Pharma Plc is a clinical stage drug development company, which engages in the development of pharmaceutical products and focus on cancer and neurological disease. Its pipeline includes SFX-01: Breast cancer, SFX-01: Subarachnoid Haemorrhage, and Other Programmes. The company was founded by Stephen Franklin in 2007 and is headquartered in Nether Alderley, CH.